(NASDAQ: PRCT) Procept Biorobotics's forecast annual revenue growth rate of 42.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Procept Biorobotics's revenue in 2024 is $136,191,000.On average, 4 Wall Street analysts forecast PRCT's revenue for 2024 to be $10,696,113,784, with the lowest PRCT revenue forecast at $10,687,195,047, and the highest PRCT revenue forecast at $10,706,561,447. On average, 4 Wall Street analysts forecast PRCT's revenue for 2025 to be $15,253,843,173, with the lowest PRCT revenue forecast at $14,863,712,138, and the highest PRCT revenue forecast at $15,590,971,429.
In 2026, PRCT is forecast to generate $20,394,603,137 in revenue, with the lowest revenue forecast at $19,865,849,448 and the highest revenue forecast at $20,923,356,826.